Drug intelligence / Profile preview

Yu-Nong formula

Development stage: Unknown
Lead developer: Yangzhong People's Hospital
Administration: Oral, Topical

Overview

Yu-Nong formula is a Traditional Chinese Medicine (TCM) therapeutic regimen developed by Yangzhong People's Hospital for the management of perianal abscesses following incision and drainage. The formula consists of a dual-modality approach: the oral administration of Jiawei Xianfang Huoxuanyin and a sitz bath using Kushen decoction. It is designed to improve postoperative outcomes, including reducing recurrence and fistula formation, accelerating wound healing, and modulating the intestinal and pus cavity microbiota. Jiawei Xianfang Huoxuanyin typically contains herbs aimed at clearing heat, detoxifying, and promoting blood circulation, while Kushen (Sophora flavescens) decoction is known for its antimicrobial and anti-inflammatory properties.

Other names: Yu-Nong formulaJiawei Xianfang Huoxuanyin plus Kushen decoction

Beyond the preview

Go deeper on Yu-Nong formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yu-Nong formula.